HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Luz Cachulo Selected Research

Myopia 13

3/2010Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Luz Cachulo Research Topics

Disease

2Choroidal Neovascularization
01/2012 - 03/2010
2Polypoidal Choroidal Vasculopathy
09/2010 - 10/2005
2Macular Degeneration (Age-Related Maculopathy)
08/2007 - 10/2005
1Central Serous Chorioretinopathy
07/2013
1Myopia
03/2010
1Myopia 13
03/2010

Drug/Important Bio-Agent (IBA)

31-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2013 - 10/2005
3Verteporfin (Visudyne)FDA Link
09/2010 - 10/2005
2Ranibizumab (Lucentis)FDA Link
01/2012 - 03/2010

Therapy/Procedure

5Photochemotherapy (Photodynamic Therapy)
07/2013 - 10/2005